The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis

<div>Funnel plots for publication bias. (a) Funnel plots without and with trim and fill to evaluate OS data. (b) Funnel plots without and with trim and fill to evaluate DFS/PFS data.</div>

Disease Markers

fig5

Figure 5

Figure 5: The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis 

Figure 5 | The Prognostic Significance of Combined Pretreatment Fibrinogen and Neutrophil-Lymphocyte Ratio in Various Cancers: A Systematic Review and Meta-Analysis 